Modifying effects of irsogladine maleate (IRG) on diethylnitrosamine (DEN)-induced hepatocarcinogenesis were examined in male F344 rats. Six-week-old rats were divided into 8 groups. Groups 1 through 4 were given a single i.p. injection of DEN (200 mg/kg body weight) at the start of the experiment, whereas groups 5 through 8 received a single i.p. injection of saline as the vehicle treatment. Groups 1 and 8 were kept on the basal diet and distilled water throughout the experiment (36 weeks). Groups 2 and 7 were exposed to 500 ppm phenobarbital (PB) in the drinking water, starting one week after the carcinogen or vehicle treatment. Groups 3 and 5 were fed the diet mixed with 125 ppm IRG from one week after DEN or vehicle treatment. Groups 4 and 6 were given 125 ppm IRG-containing diet and drinking water with 500 ppm PB after the carcinogen or vehicle treatment. Liver neoplasms developed in groups 1 (1/15 rats, 7%) and 2 (14/14 rats, 100%). However, no liver tumors were found in rats of groups 3 through 8. Incidence and average number of liver neoplasms in group 4 (0/14 rats, 0%) were less than those in group 2 (P< < < <0.0001).
Chemoprevention embraces the concept that non-carcinogenic synthetic chemicals or natural products can inhibit the process of carcinogenesis. A number of agents have proved effective against chemical carcinogenesis in different organs, 1, 2) and have been classified into two major categories, i.e., blocking and suppressing agents. 1) The mechanism of carcinogenesis is considered to involve multistep genetic alterations. Using animal models, the stages of initiation, promotion and progression have been well investigated, and in particular, studies on hepatocarcinogenesis have provided considerable information. [3] [4] [5] [6] Gap junctional intercellular communication (GJIC) has been reported to play an important role in the control of cell proliferation or differentiation, [7] [8] [9] and the modulation of GJIC is suggested to be involved in hepatocarcinogenesis, especially in the promotion phase. 8, 10) The gap junctions mediate the transfer of signal-transducing factors such as calcium, cAMP, and inositol triphosphate. 11) They are made up of oligomeric proteins composed of 6 subunits, called connexins (Cxs), and more than 10 connexins, are so far known in mammals. Among them, Cx 32 and Cx 26 are commonly expressed in hepatocytes. 12, 13) Furthermore, Cx 32 is known to decrease in preneoplastic and neoplastic lesions of the liver, while Cx 26 is reported to show a different expression pattern from that of Cx 32 in preneoplastic and neoplastic lesions. 14) Previously, we have demonstrated that in vivo exposure to liver tumor promoters, such as phenobarbital (PB) or dichlorodiphenyltrichloroethane, decreased the size and altered the distribution of gap junctions in rat hepatocytes, suggesting inhibitory effects of these agents on GJIC. 15) Agents that promote the function of gap junctions may have suppressing effects on carcinogenesis. 8) Recently, irsogladine maleate (IRG) (Fig. 1) , an antiulcer agent, has been found to enhance GJIC, [16] [17] [18] and combination chemotherapy with IRG and other agents was reported to be effective against metastatic tumors from gastric cancer. 19) We have immunohistochemically examined the effect of IRG on gap junctions of the liver, and found that IRG inhibited the decrease of Cx 32 induced by PB (unpublished data).
In the present study, we examined the possible modifying effect of IRG in a rat hepatocarcinogenesis model using diethylnitrosamine (DEN) as an initiator. Dose selection of IRG was based on maximum tolerated dose (MTD) values in the previous study. 20) IRG was administered during the promotion phase, and glutathione S-transferase placental form (GST-P)-positive preneoplastic lesions were analyzed.
MATERIALS AND METHODS
Animals, diet, drinking water and carcinogen Weanling male F344 rats, purchased from Shizuoka SLC Co., Shizuoka, were used. Powdered CE-2 (Clea Japan Inc., Tokyo) was used as a basal diet. DEN and PB were purchased from Nacalai Tesque Inc., Kyoto and Maruishi Pharm. Co., Osaka, respectively. IRG was synthesized by Nippon Shinyaku Co., Inc., Kyoto.
All animals were housed in wire cages (3 rats/cage). They had free access to water and diet under controlled environmental conditions of humidity (50±10%), lighting (12 h light/dark cycle) and temperature (23±2°C). The experimental diet mixed with IRG and drinking water containing PB were prepared weekly and stored in a cold room (4°C). Experimental procedure A total of 132 rats, 6 weeks of age, were divided into 8 groups (Fig. 2) . Animals of groups 1 through 4 received a single i.p. injection of DEN (200 mg/kg body weight) at the start of the experiment. Groups 5 through 8 were given a single i.p. injection of saline (vehicle). Rats of groups 1 and 8 were fed the basal diet alone throughout the experiment (36 weeks). Groups 2 and 7 were given drinking water containing 500 ppm PB from one week after the carcinogen or vehicle treatment. Groups 3 and 5 were fed the diet mixed with 125 ppm IRG from one week after DEN or vehicle treatment. Groups 4 and 6 were given 125 ppm IRG-containing diet and drinking water with 500 ppm PB from one week after the carcinogen or vehicle treatment. At 11 and 21 weeks after the carcinogen treatment, 3 rats from each group were killed to determine the incidence of altered liver cell foci positive for GST-P. At the termination of the experiment (36 weeks), remaining animals were killed by exposure to ether. At autopsy, the location, number and size of liver tumors were recorded. Liver tissues were sliced into 2 pieces from each sublobe. One set of slices was fixed in cold acetone and another set was fixed in 10% buffered formalin, embedded in paraffin blocks, and processed for routine histological observation with the use of hematoxylin and eosin stain. The other organs were also subjected to routine histological processing for histopathological examination. Immunohistochemical staining The liver sections from acetone-fixed tissues were stained for GST-P using the avidin-biotin-peroxidase complex method (Vectastain ABC kit, Vector Lab. Inc., Burlingame, CA).
21) Anti-GST-P antibody was provided by Dr. K. Satoh. 22, 23) The areas of GST-P-positive foci and the number of foci/cm 2 were measured by means of an image analyzer (IPAP) with a microscope (Sumitomo Chemical Co., Ltd., Osaka). GST-P-positive lesions composed of more than 11 cells were considered as altered liver cell foci. Statistical analysis Differences of incidence or density of pathological lesions in the liver between groups were analyzed by the χ 2 -test, Fisher's exact probability test or Student's t test.
RESULTS

General observation
There was no clear evidence of toxicity in the animals exposed to the IRG diet (Table I) . Two rats in group 1 and one rat in group 2 died of pneumonia before the termination of the experiment, and no neoplasms were found in them. Mean body weights of the animals given the basal diet alone (group 1), IRG diet alone (group 5), PB alone (group 7), and PB and IRG (group 6) were respectively 397±27g, 333±15g, 342±24g and 303±12g at the termination. Mean relative liver weights of the groups treated with PB were larger than those of the groups without PB treatment, though the differences were not statistically significant. In other organs, no apparent toxic effects were found in IRG-treated groups. Tumor incidence Liver tumors were recognized only in groups 1 and 2. They were all of hepatocellular origin (Table II) . Hepatocellular adenomas were found in both groups, but liver cell carcinomas were seen only in group 2. Interestingly, no hepatocellular neoplasms were present in any group exposed to IRG. The incidence of hepatocellular carcinoma or adenoma, and the incidence of total liver neoplasms of group 2 were significantly higher than those of the other groups (P<0.01). Incidence of hepatocellular foci In this study, three types of preneoplastic hepatocellular foci (clear, eosinophilic and basophilic), which were also positive for GST-P, were found in the groups exposed to DEN. The results of quantitative analysis on the frequency of GST-P-positive foci are summarized in Table III . GST-P-positive foci were seen in all the DEN-treated animals. The density and average area of GST-P-positive foci of group 2 were higher than those of group 1 or group 4 (Table III) . The density of GST-P-positive foci of group 3 was rather lower than that of group 1, although the difference was not significant. A significant decrease in the average area of GST-P-positive foci was present in the animals fed the IRG diet compared to the appropriate positive controls (P<0.001 or P<0.0001). The area of GST-P-positive foci was significantly decreased in the groups given IRG (P<0.0001).
DISCUSSION
The results of the present study clearly indicate the inhibitory effect of IRG on DEN-induced rat hepatocarcinogenesis in rats when given during the promotion phase. In this study, IRG showed a prominent suppressive effect on hepatocarcinogenesis promoted by PB, suggesting that IRG basically acted as an antipromoter. Quantitative analysis of the altered liver cell foci using the phenotypic marker GST-P was consistent with the incidences of liver neoplasms. These liver cell foci are generally recognized as preneoplastic lesions in the lineage of hepatocellular carcinoma development and are considered to reflect the carcinogenic potential, due to the consistent manner in which liver cell foci appear during the post-initiation stage of hepatocarcinogenesis. 24) IRG has been reported to enhance GJIC. [16] [17] [18] An inverse correlation between the expression of Cx 32 and BrdU labeling index has been reported in partially hepatectomized liver. 8, 9) Reduction of GJIC is suggested to be associated with the process of mitosis. 25) Thus, modulation of carcinogenesis by GJIC is considered to be important, especially in the promotion phase. genesis, together with an inverse correlation of the expression with hepatocellular proliferation, suggesting that Cx 32 expression has an important role in the hepatocarcinogenesis. 16) The results of this study are consistent with such a hypothesis.
Eghbali et al. 26) injected transfected and non-transfected human hepatoma cell lines into nude mice to examine the effect of the Cx 32 gene, and found that the tumor derived from Cx 32-transfected cells was significantly smaller than that derived from non-transfected cells. Negative growth control in vivo and in vitro was also observed in other tumorigenic cell lines transfected by gap junction genes. [27] [28] [29] [30] [31] It is speculated that connexin gene expression basically increases gap junctional protein, enhances intercellular communication and influences cell proliferation. This may be one mechanism the suppressing effect of IRG on hepatocarcinogenesis.
Recently, IRG has been reported to inhibit the induction of tissue-type plasminogen activator synthesis in endothelial cells, and the angiogenesis induced by epidermal growth factor.
32) The induction of tissue-type plasminogen activator is considered to be indispensable for growth factor-dependent angiogenesis. 33) Larson and Haudenschild have reported that junctional coupling is slightly reduced during the repair of wounded aortic endothelial cells. 34) On the other hand, Pepper and Meda indicated that migrating endothelial cells express plasminogen activator activity, while GJIC itself increases during the migration of endothelial cells. 35) These findings suggest that IRG may suppress angiogenesis, which may also play an important role in tumor growth, 36) through abrogation of the induction of plasminogen activator by modulating GJIC of endothelial cells. This could be another mechanism by which IRG suppresses hepatocarcinogenesis. In addition, IRG has been shown to activate GJIC through the M 1 muscarinic acetylcholine receptor. 18) Activation of the M 1 receptor inhibits Raf activation induced by growth factors. 37) Therefore, the suppressive effect of IRG on hepatocarcinogenesis found in the present study may be due to signaling through the M 1 muscarinic acetylcholine receptor.
In this study, body weight gain tended to be decreased by the IRG treatment, though no particular toxic effects caused by IRG were found in histopathological examination. The dose of IRG in this study was the MTD value based on the previous study. 20) Further work is needed to confirm the chemopreventive effects at lower doses.
Although more studies are necessary to confirm dosedependency, and to establish the precise mode of action of IRG and the underlying mechanisms during carcinogenesis, the results of the present investigation strongly suggest that IRG, currently being used as a therapeutic agent, could also be a promising chemopreventive agent for human liver neoplasia.
ACKNOWLEDGMENTS
We thank Dr. Kimihiko Satoh, Second Department of Biochemistry, Hirosaki University School of Medicine, for the gift of anti-GST-P antibody. We also wish to thank Ms. K. Takahashi and Mr. M. Ito for technical assistance. This work was supported in part by a Grant-in-Aid from the Ministry of Health and Welfare of Japan.
(Received October 20, 1997 /Revised January 6, 1998 Revised January 19, 1998 /Accepted January 22, 1998 
